It's just strange the way things were portrayed, that Damaj took Apricus from 16 cents to 6 dollars per share, they could have indicated that there were reverse splits in order to do so.
It could have been indicated that Damaj didn't exactly, really put in his own money into INNV in the full sense, because apparently he's taking high interest payments to make all that loaned money back, when in an interview he said he wouldn't take a salary until INNV was profitable...
(I know technically there is a difference between taking interest payments and a salary, but still it's sort of like Bill Clinton saying..."Well, it depends on what the definition of is, is.")
It could have been indicated that Damaj was awarded a bunch of INNV shares when he became the CEO and that he didn't have to pay for them. (I guess that's just common sense to know.)
Everything I noted above isn't exactly a lie on Damaj's part, but it's not exactly the complete truth either, Damaj, positively embellished everything to the extreme.
I'm not saying I could run a company better and I'm not expecting the CEO Damaj to present INNV in a negative light, but at the very least, I would have expected this...
Never, never over promise and under deliver. Always under "promise" and over deliver, just over delivering on sales/profits/forecasts, could have done a lot for the PPS.
Never hint at "promising" approval from the FDA, just say that INNV obtained the original ANDA to sell Fluticare OTC world wide via the manufacturer, if and when approval is received and that it could happen at anytime within the next 3 years. Damaj could say that typically it takes 2 years. Damaj "basically promised" with all his Fluticare hyping from 2015, through early 2017, until he finally shut his mouth.
Also, Damaj never should have given away shares of INNV prior to Fluticare approval.
I'm sure there are some things that I/we don't know, but geez it sure does seem like some missteps on Damaj's part.
I don't have allergies, but just due to the nostalgia of Fluticare, I would buy some of it, just because I've been waiting so damn look for Fluticare approval.
I wonder if I should keep buying more INNV to average down further? What scares me though, is that I chased OVIT down into bankruptcy.
I'd like to see INNV get OTC rights to Viagra and then also sell it with Vessle.
It also scares me when honeycomb states stuff like, now way Q2 will be below Xamount, that just jinxes it to be far less.
